AI assistant
Sending…
Rein Therapeutics, Inc. — Director's Dealing 2020
Jun 18, 2020
34829_dirs_2020-06-18_76d8ec82-cf6b-4460-9c8f-e3803b38880a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AILERON THERAPEUTICS INC (ALRN)
CIK: 0001420565
Period of Report: 2020-06-17
Reporting Person: MCKEE WILLIAM (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-06-17 | Stock Option (right to buy) | $1.15 | A | 12500 | Acquired | 2030-06-16 | Common Stock (12500) | Direct |
Footnotes
F1: This option was granted on June 17, 2020. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 17, 2021 or (ii) the date of the Issuer's 2021 Annual Meeting of Stockholders.
More from Rein Therapeutics, Inc.
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 28
Annual Report
2026
Apr 27
Annual Report
2026
Mar 26
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 19
Regulatory Filings
2026
Jan 16
Regulatory Filings
2025
Dec 11
Director's Dealing
2025
Nov 18